Friday, July 17

Browsing: PostTransplant

Support

How Does Orca-T Compare With Post-Transplant Cyclophosphamide for GVHD?

By NewsCancerJuly 11, 20260

Allogeneic regulatory T cell–containing immunotherapy with hematopoietic stem and progenitor cell (HSPC) and T cells-vldq (Tregzi; Orca-T) received FDA approval…

Research

CHIME: a novel HLA eplet model associates with non-relapse mortality in haploidentical hematopoietic cell transplant with post-transplant cyclophosphamide

By NewsCancerJuly 5, 20260

Pidala J, Lee SJ, Ahn KW, Spellman S, Wang HL, Aljurf M, et al. Nonpermissive HLA-DPB1 mismatch increases mortality after…

Treatments

Stem Cell Boost, Mixed Chimerism & DLI: High-Stakes Post-Transplant Choices

By NewsCancerMarch 13, 20260

Yan Leyfman, MD, looked back at a particular session hosted at the 2026 Tandem Meetings dedicated to navigating different challenges…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

01 Real-World Outcomes of Radiation Omission After Breast-Conserving Surgery in Older Women With Stage I ER-Positive Breast Cancer: A SEER Analysis (2000–2022)

Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia

OS Does Not Improve With Continuous Vs Fixed Lenalidomide Dosing in NDMM

Browsing: PostTransplant

How Does Orca-T Compare With Post-Transplant Cyclophosphamide for GVHD?

CHIME: a novel HLA eplet model associates with non-relapse mortality in haploidentical hematopoietic cell transplant with post-transplant cyclophosphamide

Stem Cell Boost, Mixed Chimerism & DLI: High-Stakes Post-Transplant Choices

01 Real-World Outcomes of Radiation Omission After Breast-Conserving Surgery in Older Women With Stage I ER-Positive Breast Cancer: A SEER Analysis (2000–2022)

Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia

OS Does Not Improve With Continuous Vs Fixed Lenalidomide Dosing in NDMM

How Do Updated NCCN Guidelines and ctDNA Data Reshape MIBC Treatment?

01 Real-World Outcomes of Radiation Omission After Breast-Conserving Surgery in Older Women With Stage I ER-Positive Breast Cancer: A SEER Analysis (2000–2022)

Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia

OS Does Not Improve With Continuous Vs Fixed Lenalidomide Dosing in NDMM

How Do Updated NCCN Guidelines and ctDNA Data Reshape MIBC Treatment?

Latest Post

01 Real-World Outcomes of Radiation Omission After Breast-Conserving Surgery in Older Women With Stage I ER-Positive Breast Cancer: A SEER Analysis (2000–2022)

Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia

OS Does Not Improve With Continuous Vs Fixed Lenalidomide Dosing in NDMM

Subscribe to Updates

What's Hot

Browsing: PostTransplant